Aetna Inc. (NYSE:AET) – Analysts at Oppenheimer Holdings decreased their Q4 2017 earnings per share (EPS) estimates for shares of Aetna in a report issued on Thursday. Oppenheimer Holdings analyst M. Wiederhorn now anticipates that the company will earn $1.31 per share for the quarter, down from their previous estimate of $1.66.

Other research analysts have also issued reports about the company. UBS AG reaffirmed a “buy” rating and issued a $160.00 price objective (up from $147.00) on shares of Aetna in a report on Wednesday, May 17th. Argus reaffirmed a “buy” rating and issued a $165.00 price objective (up from $145.00) on shares of Aetna in a report on Tuesday, May 30th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $175.00 price objective (up from $150.00) on shares of Aetna in a report on Wednesday. Credit Suisse Group reaffirmed a “buy” rating and issued a $155.00 price objective on shares of Aetna in a report on Wednesday, May 17th. Finally, Cleveland Research raised Aetna from a “neutral” rating to a “buy” rating in a report on Thursday, May 11th. Eight equities research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $157.09.

TRADEMARK VIOLATION WARNING: “Aetna Inc. (NYSE:AET) Forecasted to Post Q4 2017 Earnings of $1.31 Per Share” was posted by Daily Political and is the property of of Daily Political. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.dailypolitical.com/2017/08/09/aetna-inc-nyseaet-forecasted-to-post-q4-2017-earnings-of-1-31-per-share.html.

Aetna (AET) traded down 0.12% during midday trading on Monday, reaching $156.09. 654,932 shares of the company’s stock were exchanged. The company has a 50 day moving average price of $153.85 and a 200 day moving average price of $137.83. The company has a market cap of $51.78 billion, a P/E ratio of 47.60 and a beta of 0.54. Aetna has a 12 month low of $104.59 and a 12 month high of $161.69.

Aetna (NYSE:AET) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The firm had revenue of $15.52 billion for the quarter, compared to the consensus estimate of $15.34 billion. During the same quarter in the previous year, the company earned $2.21 earnings per share. The business’s revenue was down 2.7% compared to the same quarter last year.

A number of institutional investors have recently bought and sold shares of AET. Liberty Capital Management Inc. increased its position in Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock valued at $144,000 after buying an additional 629 shares in the last quarter. FTB Advisors Inc. increased its position in Aetna by 11.0% in the first quarter. FTB Advisors Inc. now owns 977 shares of the company’s stock valued at $125,000 after buying an additional 97 shares in the last quarter. Signature Estate & Investment Advisors LLC purchased a new position in Aetna during the first quarter valued at approximately $133,000. Horan Capital Management purchased a new position in Aetna during the first quarter valued at approximately $157,000. Finally, Deschutes Portfolio Strategy LLC purchased a new position in Aetna during the second quarter valued at approximately $200,000. Hedge funds and other institutional investors own 91.73% of the company’s stock.

In other Aetna news, EVP Margaret M. Mccarthy sold 27,028 shares of the stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total value of $4,033,388.44. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares in the company, valued at $5,008,606.49. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Chairman Mark T. Bertolini sold 103,547 shares of the stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $140.79, for a total value of $14,578,382.13. Following the completion of the transaction, the chairman now owns 659,888 shares of the company’s stock, valued at $92,905,631.52. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Thursday, July 13th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 1.28%. The ex-dividend date was Tuesday, July 11th. Aetna’s dividend payout ratio (DPR) is presently 43.67%.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Earnings History and Estimates for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.